VBI Vaccines
VBIV
#10529
Rank
NZ$3.23 M
Marketcap
NZ$0.11
Share price
0.00%
Change (1 day)
-89.32%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): NZ-$16.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is NZ-$17.53. In 2022 the company made an earnings per share (EPS) of NZ-$22.82 a decrease over its 2021 EPS that were of NZ-$14.00.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$16.49
2022NZ-$22.8262.96%
2021NZ-$14.0028.57%
2020NZ-$10.89-54.35%
2019NZ-$23.85-52.58%
2018NZ-$50.3010.23%
2017NZ-$45.6414.29%
2016NZ-$39.93-62.8%
2015NZ-$107.3590.68%
2014NZ-$56.30-7.95%
2013NZ-$61.16-57.97%
2012NZ-$145.54-78%
2011NZ-$661.623151.47%
2010NZ-$20.3523.87%
2009NZ-$16.43-18.48%
2008NZ-$20.1512.08%
2007NZ-$17.98-49.47%
2006NZ-$35.59
2005N/A-100%
2004NZ-$15.8211.94%
2003NZ-$14.13-81.89%
2002NZ-$78.04196.44%
2001NZ-$26.3284.33%
2000NZ-$14.28-65.37%
1999NZ-$41.24-29.45%
1998NZ-$58.4529.61%
1997NZ-$45.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
NZ-$1.64-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$7.48-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
NZ-$6.34-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA